Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 CLEAR DIFFERENTIATION AMONG PSYCHEDELIC DRUG DEVELOPMENT COMPANIES Tryp is one of just a handful of psychedelic drug development companies that will be conducting Phase 2 clinical trials in 2021. While mental health indications such as depression, anxiety, and addiction are crowded by multiple companies, Tryp Therapeutics is breaking new ground in chronic pain and other indications. 29 Competitive Landscape: Psychedelic Drug Development Companies